Healthcare / Drug Manufacturers - Specialty & GenericUpdated 2026-05-10 22:07 UTC

ELAN stock hub

Elanco Animal Health Incorporated has a live ticker hub with the latest available market, valuation, profitability, growth, ownership, and risk indicators.

Browse stocks

ELANis not in this month’s coverageGet our monthly research letter — no spam

Fair value midpoint

n/a

Fair value pending

Upside to midpoint

n/a

Based on latest report

Confidence

n/a

Data quality and model convergence

Market cap

11.8B

NYSE

Market data

Live price

Current market quote for this ticker.

Current price

ELAN

In the news

Latest news · ELAN

Recent company headlines from major financial publishers.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

—

Fetching the latest headlines.

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector context

Where the current metrics sit

Percentiles come from the backend screener cohort cache for the ticker's country and sector.

Forward P/E22.3

P25 12.3P50 18.4P75 33.1

Trailing P/En/a

P25 14.9P50 23.2P75 38.5

ROE-3.8

P25 -105.6P50 -46.5P75 -3.1

ROIC2.9

P25 -63.1P50 -27.3P75 0.5

Benchmarks - 1M

S&P 500n/a

Nasdaq Compositen/a

Dow Jones Industrial Averagen/a

Russell 2000n/a

Indicator catalog

All ELAN market and fundamental indicators

A searchable catalog of the available market, valuation, profitability, growth, balance-sheet, ownership, and analyst metrics for this ticker.

Available fields

238

Groups with data

Currency

USD

Showing 238 of 238 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Cik	0001739104
Company name	Elanco Animal Health Incorporated
Country	United States
Country code	US
Cusip	28414H103
Employees	9,900
Employees Change	450%
Employees Change Percent	4.76
Enterprise value	$15.7B
Exchange	NYSE
Financial currency	USD
First seen	2026-05-09
Industry	Drug Manufacturers - Specialty & Generic
IPO Date	2018-09-20
Isin	US28414H1032
Last refreshed	2026-05-10
Market cap	$11.8B
Market cap category	Large-Cap
Price	$23.65
Price currency	USD
Rev Per Employee	494,242.42x
Sector	Healthcare
Sic	2834
Symbol	ELAN
Website	https://www.elanco.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-2.05%
EV Sales Forward	3.03x
EV/EBIT	51.09x
EV/EBITDA	16.17x
EV/FCF	49.79x
EV/Sales	3.21x
FCF yield	2.67%
Forward P/E	22.25x
P/B ratio	1.82x
P/S ratio	2.41x
PEG ratio	1.79x
PS Forward	2.29x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
EBIT Margin	6.27%
EBITDA Margin	19.82%
FCF margin	6.44%
Gross margin	55.06%
Gross Profit	$2.7B
Gross Profit Growth	10.86%
Gross Profit Growth Q	14.77%
Gross Profit Growth3 Y	1.93%
Gross Profit Growth5 Y	5.68%
Net Income	$-242M
Net Income Growth Q	-14.93%
Net Income Growth Years	0%
Pretax Margin	-4.03%
Profit Margin	-4.95%
Profit Per Employee	$-24,444
ROA	1.47
Roa5y	1.34
ROCE	2.66
ROE	-3.77
Roe5y	-4.7
ROIC	2.95
Roic5y	2.5

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	97.01%
Cagr3y	36.44%
Cagr5y	-6.38%
EPS Growth Q	-15.39
EPS Growth Years	0
FCF Growth	-9.22%
FCF Growth3 Y	17.74%
OCF Growth	7.85%
OCF Growth3 Y	16.07%
Revenue Growth	10.53x
Revenue Growth Q	14.92x
Revenue Growth Quarters	4x
Revenue Growth Years	3x
Revenue Growth3 Y	3.28x
Revenue Growth5 Y	4.87x

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Asset Turnover	$0.37
Assets	$13.2B
Cash	$428M
Current Assets	$3.6B
Current Liabilities	$1.7B
Debt	$4.3B
Debt EBITDA	$4.12
Debt Equity	$0.66
Debt FCF	$13.65
Equity	$6.5B
Interest Coverage	1.17
Liabilities	$6.7B
Long Term Assets	$9.6B
Long Term Liabilities	$5.1B
Net Cash	$-3.9B
Net Cash By Market Cap	$-32.78
Net Debt EBITDA	$3.99
Net Debt Equity	$0.6
Net Debt FCF	$12.29
Tangible Book Value	$-1.4B
Tangible Book Value Per Share	$-2.9
WACC	11.2

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	2.16
Inventory Turnover	1.33
Net Working Capital	$1.6B
Quick ratio	0.95
Working Capital	$1.9B
Working Capital Turnover	$2.39

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	0.21%
Dividend Yield	0%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	96.92%
200-day SMA	21.72
3Y total return	154.03%
50-day SMA	23.65
50-day SMA vs 200-day SMA	50over200
5Y total return	-28.07%
All Time High	37.61
All Time High Change	-37.12%
All Time High Date	2018-09-27
All Time Low	7.88
All Time Low Change	200.13%
All Time Low Date	2023-05-31
ATR	1.16
Beta	1.69
Beta1y	1.34
Beta2y	1.12
Ch YTD	4.51
High	24.58
High52	27.72
High52 Date	2026-02-25
High52ch	-14.68%
Low	22.91
Low52	11.83
Low52 Date	2025-05-08
Low52ch	99.92%
Ma50ch	0.01%
Premarket Change Percent	1.21
Premarket Price	$24.3
Premarket Volume	24,556
Price vs 200-day SMA	8.88%
RSI	51.82
RSI Monthly	61.28
RSI Weekly	55.44
Sharpe ratio	1.74x
Sortino ratio	3.31
Total Return	0.21%
Tr YTD	4.51
Tr1m	3.73%
Tr1w	5.06%
Tr3m	-6.15%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Analyst Count	10
Analyst Count Top	3
Analyst Price Target Top	$25.67
Analyst Ratings	Strong Buy
Analyst Ratings Top	Buy
Earnings EPS Estimate	$0.34
Earnings EPS Estimate Growth	-8.11
Earnings Revenue Estimate	1,276,482,744x
Earnings Revenue Estimate Growth	7x
Operating Income	$307M
Operating Income Growth	25.31
Operating Income Growth Q	39.67
Operating Income Growth3 Y	-10.97
Operating Income Growth5 Y	28.68
Operating margin	6.27
Price target	$28.22
Price Target Change	$19.32
Price Target Change Top	$8.54

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	494,941,894%
Float Percent	99.1%
Net Borrowing	-361,000,000
Shares Insiders	0.76%
Shares Institutions	109.31%
Shares Out	499,449,583
Shares Qo Q	1.83%
Shares Yo Y	-0.21%
Short Float	4.96%
Short Ratio	4.11
Short Shares	4.92

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	$241M
Average Volume	5,370,344.65x
Bv Per Share	13.02
CAPEX	$-262M
Ch1m	3.73
Ch1w	5.06
Ch1y	96.92
Ch3m	-6.15
Ch3y	154
Ch5y	-28.07
Ch6m	10.05
Change	-1.5%
Change From Open	-2.11
Close	24.01
Days Gap	0.62
Depreciation Amortization	663,000,000
Dollar Volume	196,009,804.7
Earnings Date	2026-05-06
Earnings Time	bmo
EBIT	$307M
EBITDA	$970M
EPS	$-0.49
F Score	6
FCF	$315M
FCF EV Yield	2.01x
FCF Per Share	$0.63
Financing CF	-392,000,000
Fiscal Year End	December
Founded	1,954
Goodwill	4,723,000,000
Income Tax	$45M
Investing CF	-281,000,000
Is Primary Listing	1
Is Spac	No
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Last Split Type	Never
Last10k Filing Date	2026-02-24
Ma150	23.11
Ma150ch	2.33%
Ma20	23.11
Ma20ch	2.35%
Net CF	-59,000,000
Next Earnings Date	2026-08-06
Open	24.16
Optionable	Yes
P FCF Ratio	37.5
P OCF Ratio	20.47
Position In Range	44.31
Post Close	23.65
Postmarket Change Percent	-1.95
Postmarket Price	$23.19
Ppne	1,395,000,000
Pre Close	24.01
Price Date	2026-05-08
Price EBITDA	$12.18
Relative Volume	1.54x
Revenue	4,893,000,000x
SBC By Revenue	1.51x
Share Based Comp	74,000,000
Tax By Revenue	0.92x
Tr6m	10.05%
Us State	Indiana
Volume	8,287,941
Z Score	1.22

Fast facts

Decision checkpoints

A compact product layer over the same report payload.

Risk gate

n/a

Named kill scenarios are reviewed before any bullish rating can stand.

Moat score

n/a

Business quality stays separate from stock attractiveness.

Forward P/E

n/a

Valuation uses the full report model stack, not a single multiple.

Next action

Research pending

Final action steps are kept in the recommendation tab.

Income

Does ELAN pay a dividend?

Capital-return profile for this ticker.

Performance

ELAN stock returns vs the market

Total return (incl. dividends) compared to S&P 500.

Ownership

Who owns ELAN?

Insider, institutional, and short-interest positioning.

Institutional ownership

+109.3%

Float: +99.1% of shares outstanding

Insider ownership

+0.8%

Stake held by company insiders. Higher generally signals alignment.

Negative means the company is buying back shares.

Technical

ELAN momentum and risk profile

RSI, moving-average stack, beta, and risk-adjusted return.

RSI (14)

51.8

Neutral momentum band

Price vs 200-day MA

+8.9%

50/200-day relationship not available

Beta (5Y)

1.69

More volatile than the market

Sharpe ratio

1.74

Risk-adjusted return — higher is better; >1.0 is solid.

Questions

About ELAN

Hub-level FAQ points readers to the deeper analysis pages.

What is the current ELAN stock rating?

Elanco Animal Health Incorporated is currently shown with the latest rating in the latest report. The hub links directly to the full analysis surface where the rating, fair-value bridge, risks, and scorecard are documented together.

Where can I read the full ELAN analysis?

The full report lives at /stocks/ELAN/analysis. The bare ticker page is a product hub that summarizes the latest read and sends readers into the relocated analysis tabs without making the analysis surface depend on the hub.

What fair-value range is used for ELAN?

The latest report frames ELAN around the latest fair-value range. Treat that range as the entry point, then check the valuation, sensitivity, and bear-case tabs before making an investment decision.

How often is the ELAN page updated?

The hub updates with the latest published stock report and live backend market data. The analysis pages remain reachable under /analysis, so a hub rollback does not remove the report reader.